19-year-old college student dies in the U.S. after overdosing on medication following ChatGPT medical advice; family sues OpenAI

A family in the U.S. has sued OpenAI and CEO Sam Altman after a 19-year-old college student allegedly died from following ChatGPT’s medical advice.

The complaint says ChatGPT encouraged dangerous drug combinations and near-lethal doses, including kratom, Xanax, and Benadryl, without urging medical care.

The case centers on whether AI companies are responsible when their chatbots provide harmful health guidance.

It also raises broader questions about safety safeguards for generative AI used as a substitute for medical advice.